Ethiopia: Ethiopia's Growing Malaria Drug Resistance Posing Threat to Frontline Treatment, New Study Reveals
[Addis Standard] Addis Abeba -- A nationwide genomic surveillance study has identified widespread antimalarial drug-resistance markers in Ethiopia, including mutations associated with partial artemisinin resistance, raising concerns over the continued effectiveness of artemether-lumefantrine, the country's first-line treatment for Plasmodium falciparum malaria.
We haven't written up this one. AllAfrica Health has the full story — the link below goes straight to it.
